Roadmap to Success

9:00 a.m. - 9:55 a.m., Tuesday, October 8th, 2013, Twin Peaks North/South

Given declining research funds from private and public sources, avoidance of risk investment, increased R&D costs and regulatory challenges, companies and foundations share the need for fresh approaches and more efficient pathways to market.  Those life science companies that can harness the power of patient groups will get to the market faster, cheaper and smarter, helping patients and rewarding investors.  Though foundations bring urgency, intelligence and resources that can be essential to accelerating key steps in the drug development process, very few companies understand how to foster successful collaborations, overcome differences in their agendas and resources. To help foster more of these partnerships across the industry, BayBio recently completed the first national assessment of such collaborations -- to extract what is working well and what may lead to failure -- from a strong sample set of case studies and relationships.  Through this work, BayBio provides a roadmap – both for life science companies and patient groups – of how to explore, form and navigate successful outcomes from the pioneers who led the way.

Participating patient advocacy groups currently include ALS Therapy Development Institute and the Parent Project Muscular Dystrophy. Please stay tuned for more information.